Pfizer/BioNTech COVID-19 Vaccination Could Protect Pregnant Women, Newborns, Study In Israel Suggests: Reuters

Loading...
Loading...

According to a small study conducted in Israel, pregnant women vaccinated against COVID-19 could pass along protection to their babies, Reuters reported.

  • In the research conducted in February, antibodies were detected in all 20 women who got both doses of the Pfizer Inc (NYSE) / BioNTech SE BNTX vaccine during their third trimester of pregnancy and in their newborns through placental transfer.
  • “Our findings highlight that vaccination of pregnant women may provide maternal and neonatal protection from SARS-CoV-2 infection,” the study said.
  • The authors noted the small size of the study and said further research was necessary to measure the effect of vaccination at different stages of pregnancy.
  • Pfizer/BioNTech said last month they had started a 4,000-volunteer international study to evaluate the safety and effectiveness of their COVID-19 vaccine in healthy pregnant women.
  • The trial will also assess whether vaccinated pregnant women transfer protective antibodies to their babies.
  • Price Action: PFE shares are down 0.03% at $35.82, and BNTX shares were trading 2.8% lower at $105.08 in market trading hours on the last check Wednesday.
Posted In: BiotechNewsHealth CareFDAGeneralCOVID-19 VaccinepregnancyReuters
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...